To evaluate whether different biomarkers can stratify patients with newly diagnosed GBM that have progressive enhancement within 12 weeks post-XRT into risk groups based on overall survival.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Yueh Lee
Radiology - Research
Clinical or Medical
Interventional
Cancer (Brain and Other Nervous System)
25-1570
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
